News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Valeant Pharmaceuticals International
NEWS
IN THE PRESS
NEWS
Valeant Pharmaceuticals International was acquired by Bausch & Lomb in 2013.
Deals
As Sarepta And Valeant Exit Hearings, Biotech Steps Into M&A
May 3, 2016
·
1 min read
Business
Valeant’s New CEO Will Make Over $500 Million if Stock Hits $270 By 2020
April 28, 2016
·
3 min read
Business
Critics Believe New Valeant CEO Joe Papa Jumped from One Troubled Drugmaker to Another
April 26, 2016
·
3 min read
Business
Perrigo Names New CEO as Joseph Papa Joins Rival Valeant
April 25, 2016
·
3 min read
Business
Valeant Close to Naming Perrigo’s Joseph Papa as New CEO
April 22, 2016
·
3 min read
Deals
Biogen, Regeneron and Valeant Rank High as Potential Takeover Targets for Allergan
April 21, 2016
·
3 min read
Deals
Covered in $30 Billion Debt, Embattled Valeant Mulls Over Which Assets to Sell
April 19, 2016
·
3 min read
Deals
Embattled Valeant Working with Banks to Review Options Amid Interest from Buyout Firms
April 15, 2016
·
3 min read
Genetown
Cures Within Reach: “Creating The Opposite Of Valeant”
April 14, 2016
·
1 min read
IN THE PRESS
Valeant Comments On Press Report
November 1, 2016
·
1 min read
Business
Valeant Announces Third Quarter Financial Results Date And Conference Call Details
October 18, 2016
·
1 min read
Business
Valeant Breaks Up With Mail-Order Pharmacy That Helped Sell Older Drugs
October 18, 2016
·
1 min read
Policy
Valeant Patient Access And Pricing Committee Comments On Recent Pricing Action Decisions
October 14, 2016
·
4 min read
Business
Valeant Appoints Louis W. Yu, Ph.D. As Chief Quality Officer
October 7, 2016
·
3 min read
Valeant Comments On Discount And Rebate Program For Nitropress And Isuprel
September 19, 2016
·
2 min read
Business
EyeGate Pharma Receives Additional Milestone Payment From Valeant For EGP-437
September 12, 2016
·
3 min read
Deals
Valeant CEO Says He’ll Never Say Never to Selling Core Assets Like Bausch & Lomb
September 8, 2016
·
1 min read
Valeant And Progenics Announce The U.S. Commercial Launch Of FDA-Approved Relistor Tablets
September 7, 2016
·
7 min read
Valeant To Participate In September Healthcare Conferences
August 31, 2016
·
1 min read
